# Non-Synaptic Mechanism of Ocular Dominance Plasticity

**Authors:** Maxwell K. Foote, William C. Huffman, Erin N. Santos, Philip R. Lee, Michal Jarnik, Wei Li, Juan S. Bonifacino, R. Douglas Fields

PMC · DOI: 10.1080/17590914.2026.2616376 · ASN NEURO · 2026-01-20

## TL;DR

The study reveals a new non-synaptic mechanism in the brain's visual system that changes how eyes influence vision, involving myelin changes rather than just synaptic connections.

## Contribution

The paper introduces a non-synaptic mechanism of ocular dominance plasticity mediated by myelin-forming cells.

## Key findings

- Monocular visual disruption alters spike time arrival in the visual cortex.
- Morphological changes in myelin on axons are associated with this disruption.
- This non-synaptic mechanism may drive or supplement synaptic plasticity.

## Abstract

Classic experiments showing that monocular visual disruption alters synaptic connections to binocular neurons established the fundamental concept of synaptic plasticity. Synaptic inputs that are activated coincidently with postsynaptic action potential firing are strengthened, and inputs from cells firing before or after the postsynaptic action potential are weakened. An implicit assumption, however, is that the speed of impulse transmission is not altered by visual deprivation. If so, spike time arrival at binocular neurons would be affected, thereby inducing synaptic plasticity. This possibility is tested here in adult mice by monocular eyelid suture and monocular action potential inhibition in retinal axons. The results show that spike time arrival in visual cortex is altered by monocular visual disruption in association with morphological changes in myelin (nodes of Ranvier) on axons in optic nerve and optic tract. This non-synaptic mechanism of ocular dominance plasticity, mediated by myelin-forming cells, supplements and may drive synaptic plasticity.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cntnap1 (contactin associated protein-like 1) [NCBI Gene 53321] {aka Caspr, NCP1, Nrxn4, p190, shm}, Mbp (myelin basic protein) [NCBI Gene 17196] {aka Hmbpr, golli-mbp, jve, mld, shi}, Scn8a (sodium channel, voltage-gated, type VIII, alpha) [NCBI Gene 20273] {aka C630029C19Rik, NaCh6, Nav1.6, dmu, med, mnd-2}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, KCNJ2 (potassium inwardly rectifying channel subfamily J member 2) [NCBI Gene 3759] {aka ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7}, Slc17a6 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6) [NCBI Gene 140919] {aka 2900073D12Rik, DNPI, VGLUT2}, Prl (prolactin) [NCBI Gene 19109] {aka Gha1, Prl1a1}, Rbpms (RNA binding protein gene with multiple splicing) [NCBI Gene 19663] {aka 2010300K22Rik, 2700019M19Rik, RBP-MS, hermes}, Ybx1 (Y box protein 1) [NCBI Gene 22608] {aka 1700102N10Rik, EF1A, MSY1, Nsep1, YB-1, dbpB}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Hmgcr (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) [NCBI Gene 15357] {aka HMG-CoAR, Red}, Kcnj2 (potassium inwardly-rectifying channel, subfamily J, member 2) [NCBI Gene 16518] {aka IRK1, Kcnf1, Kir2.1}
- **Diseases:** atrophy (MESH:D001284), demyelinating diseases (MESH:D003711), ocular injury (MESH:D005131), MI (MESH:C565433), OMP (MESH:D010411), infection (MESH:D007239), monocular visual disruption (MESH:D014786), MD (MESH:D012892), pain (MESH:D010146), sleep (MESH:D012893), trauma (MESH:D014947), amblyopia (MESH:D000550), depression (MESH:D003866)
- **Chemicals:** silicone (MESH:D012828), cacodylate (MESH:D002101), sodium acetate (MESH:D019346), CTB 488 (-), Sodium (MESH:D012964), Proparacaine Hydrochloride (MESH:C005717), DAPI (MESH:C007293), Ketamine (MESH:D007649), Ciprofloxacin (MESH:D002939), carprofen (MESH:C007005), calcium (MESH:D002118), glutamate (MESH:D018698), glutaraldehyde (MESH:D005976), Epon 812 (MESH:C004875), AlexaFluor 555 (MESH:C000608607), Oil (MESH:D009821), Phenylephrine Hydrochloride (MESH:D010656), Xylazine (MESH:D014991), sucrose (MESH:D013395), copper (MESH:D003300), TTX (MESH:D013779), uranyl acetate (MESH:C005460), osmium tetroxide (MESH:D009993), PFA (MESH:C003043), Triton X-100 (MESH:D017830), acetone (MESH:D000096), ethanol (MESH:D000431)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Bos taurus (bovine, species) [taxon 9913]
- **Mutations:** T2A
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12826708/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12826708/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12826708/full.md

---
Source: https://tomesphere.com/paper/PMC12826708